Mike Sergesketter
Analyst · Gabelli & Company. Your line is open
Thanks, Don. During my comments, I will be referring to the slide deck Don mentioned, which can be found on our Investor Relations website within the Events & Presentations tab; or if you’re listening via webcast, you can find it in the downloads tab on the webcast portal. As shown on Slide 3, our third quarter net sales were a record $283.9 million, which was a 22% increase compared to net sales of $232.9 million in the prior year third quarter. Partially assisting in the increase from a year ago was the favorable exchange rate movements which accounted for 7% of our net sales growth. Slide 4 represents our net sales mix by vertical market. Comparing our net sales by vertical to the same quarter a year ago, our automotive vertical was up over 40% compared to a year ago to a new quarterly record of $136.2 million. The increase from a year ago was largely due to the ramp-up of new program introductions as well as strong demand in all three of our geographic markets. Our medical vertical was up 30% in the current quarter compared to Q3 of last year from both increased demand for existing programs and the ramp-up of new programs. Our industrial vertical was down a slight 1% from a year ago as increases from the continued ramp-up of new product launches related to smart metering devices was more than offset by the exit of certain programs and softer demand in other existing programs. Lastly, our public safety vertical was down by double digits from the prior year third quarter as a result of overall demand and programs reaching end of life. Our gross margin in the third quarter, reflected on Slide 5, was 8.1%, which was up slightly from 8% in the same quarter last year and was flat sequentially from the second quarter of this fiscal year. Our increase in the gross margin in the current year quarter compared to a year ago was the result of leverage from the higher sales, which was partially offset by the impact of costs associated with the support of new product introductions and a less favorable product mix. Selling and administrative expenses, Slide 6 in the deck, were $11.7 million in the third quarter, which were up $2.5 million in absolute dollars, and up 30 basis points compared to the prior year third quarter. The increase in selling and administrative absolute dollars compared to the prior year was in part due to increased employee costs, including salary expense and related benefit costs, and incentive compensation costs, including noncash stock compensation expense which accounted for a 20 basis point increase. Partially offsetting the increased S&A costs were lower expenses related to the normal revaluation of the Supplemental Employee Retirement Plan, or SERP, liability. Our operating income for the third quarter, on Slide 7 in the deck, came in at $11.2 million, or 3.9% of sales, which compares to operating income of $9.5 million or 4.1% of net sales in the same period a year ago. Other income net was $1.9 million in the fiscal year 2018 third quarter compared to income of $300,000 in the third quarter of fiscal year 2017. Other income net, in the current year third quarter was primarily the result of $2.1 million in net foreign currency exchange gains driven by strengthening of the currencies in our foreign locations compared to the U.S. dollar. In the prior year third quarter, other income net, included a $400,000 gain on the fair value of the investments in our Supplemental Employee Retirement Plan and less than $100,000 in net foreign currency exchange gains. The effective tax rate for the current year third quarter was 17.5% compared to 17.8% effective tax rate in the prior year third quarter. In the current year quarter, we recognized approximately $200,000 of discrete tax benefits, including $100,000 related to a measurement period adjustment in the revaluation of the deferred tax assets associated with tax reform. In the prior year third quarter, we recognized approximately $500,000 of discrete tax benefits. The reduction in the U.S. corporate tax rate to a blended 28.1% for our fiscal year 2018 did not have a significant impact on our effective tax rate for the current quarter. Slide 8 reflects our adjusted net income trend. Our reported GAAP net income in the third quarter of fiscal year 2018 came in with a new quarterly record of $10.8 million which is a 33% increase compared to the $8.1 million of net income recorded in the third quarter of fiscal year 2017. Our non-GAAP adjusted net income was $10.7 million in the current year third quarter, excluding the tax reform measurement period adjustment I mentioned previously. Diluted earnings per share ended up at a quarterly record of $0.40 for the third quarter of this fiscal year, which compares to $0.30 for the same quarter last year. Cash and cash equivalents at March 31, 2018, were $44.2 million. Operating cash flow trends are shown on Slide 11. Our cash flow from operations during the current year third quarter was $9.5 million, as our net income plus non-cash items more than offset usage of cash related to an increase in working capital, primarily from an increase in receivables related to the higher sales levels. Our cash flow from operating activities in the prior year third quarter was $8.7 million. Our cash conversion days increased one day from the – for the three months ended March 31, 2018, when compared to the same period in the prior year as our PDSOH, or Production Days Sales On Hand, which is our inventory metric, increased by five days to support increased volumes and the implantation of a new inventory management program for 1 of our largest medical customers, which more than offset a four day decline in our DSO, or days sales outstanding, which is our receivables metric, partly from higher volumes and faster payments from customers utilizing factoring programs. Slide 12 reflects our capital and depreciation trends. Capital investments in the third quarter totaled $7.2 million, largely related to our investment in new manufacturing equipment to support new production awards and increase manufacturing capacity. Borrowings on our credit facilities at March 31, 2018, were $16.3 million, which was up $6.3 million from June 30, 2017. Our short-term liquidity available represented as cash and cash equivalents plus the unused amount of our credit facilities, totaled $99 million at March 31, 2018. I’d like to conclude by saying that our balance sheet continues to be strong, and I believe we’re well positioned for continued growth. With that, I would like to open up today’s call to questions from the analysts. Norma, do we have any analysts with questions in the queue?